News | Interventional Radiology | April 22, 2019

Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions

Mentice will provide IR simulators, hardware and expertise through 501c3 nonprofit organization

Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions

April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprofit public service RAD-AID to donate high-fidelity simulators for interventional radiology (IR) procedure training in various resource-constrained regions of the world. Under the agreement, Mentice pledges to contribute simulator software, hardware and expertise to RAD-AID IR educational teams.

Launched in 2008, RAD-AID is a 501c3 nonprofit organization committed to bringing radiology and imaging technologies and solutions to developing countries and medically underserved communities.

RAD-AID is active in over 30 countries worldwide, and encompasses over 10,000 volunteers from 100 countries, 73 university-based chapter organizations, and an annual conference on global health radiology. “RAD-AID programs are multidisciplinary and bring together innovative technology, infrastructure-planning, and educational initiatives. Such multidisciplinary cooperation is essential, and by working with Mentice, we can help bring effective IR programs to some of the world’s neediest patients,” said Daniel Mollura, M.D., founder and CEO of RAD-AID International.

For more information: www.rad-aid.org

Related Content

Varian Purchasing Embolic Bead Assets from Boston Scientific
News | Interventional Radiology | July 03, 2019
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable...
Mentice and Siemens Healthineers Integrate VIST Virtual Patient With Artis Icono Angiography System
Technology | Interventional Radiology | June 24, 2019
Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into...
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
Merit Medical Acquires Brightwater Medical Inc.
News | Interventional Radiology | June 19, 2019
Merit Medical Systems Inc. announced it has acquired Brightwater Medical Inc., based in Temecula, Calif. Brightwater...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Philips Launches IntraSight Interventional Applications Platform
Technology | Interventional Radiology | May 20, 2019
Philips announced the launch of the new IntraSight interventional applications platform. The secure, application-based...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing
Ultrasonic Device Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy
News | Interventional Radiology | May 06, 2019
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of...